Generic policy in Bulgaria: a policy of failure or success?
Generic medicines play a key role in managing the financial resources for pharmaceuticals in every country. This study analysed the generic policy legislative framework in Bulgaria with the aim to identify whether the policy implementation can be considered successful in the light of an internationa...
Main Authors: | Assena Stoimenova, Stefan Penkov, Alexandra Savova, Manoela Manova, Guenka Petrova |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2016-09-01
|
Series: | Biotechnology & Biotechnological Equipment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13102818.2016.1208061 |
Similar Items
-
Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners
by: Virgil Beauvais, et al.
Published: (2018-11-01) -
Knowledge and Perceptions of Final-Year Medical Students in Yemeni Universities about Generic Medicines
by: Gamil Q. Othman, et al.
Published: (2016-02-01) -
Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
by: F. Cankat Tulunay, et al.
Published: (2010-08-01) -
Generics and fixed-dose combinations in cardiology: satisfaction analysis of pharmacists and cardiologists
by: Guenka Petrova, et al.
Published: (2016-01-01) -
Maximum potential cost-savings attributable to generic substitution of antipsychotics 2008 to 2013
by: D. Husselmann, et al.
Published: (2016-12-01)